Mensifem

Cimicifuga racemosa dry extract, the active ingredient in Mensifem, is a herbal botanical presented as a dry extract for oral use. It is intended to help relieve menopausal symptoms such as hot flashes in adult women. The extract is derived from the rhizome of Black Cohosh and is supplied in a standardized concentration.

GNH USA supplies Mensifem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mensifem, a herbal botanical, is used to manage various menopausal symptoms. - Menopausal hot flashes: reduction in frequency and intensity of sudden heat sensations. - Night sweats: decrease in nocturnal sweating episodes. - Vaginal dryness: improvement in lubrication and comfort. - Mood swings: support for emotional stability during hormonal changes. - Sleep disturbances: promotion of more restful sleep patterns.

Mensifem may be associated with several adverse reactions, which are categorized by frequency and severity. Common Side Effects: - Gastrointestinal upset: mild nausea or stomach discomfort. - Headache: transient mild to moderate pain. - Skin rash: mild erythema or itching. Serious or Rare Side Effects: - Liver enzyme elevation: signs of hepatic stress requiring monitoring. - Severe allergic reaction (anaphylaxis): swelling, breathing difficulty. - Blood clot formation: rare thrombotic events.

Before using Mensifem, consider the following precautions. - Pregnancy: safety not established; avoid use unless advised by a physician. - Breastfeeding: insufficient data; consider alternative therapies. - Hormone‑sensitive conditions: use with caution due to possible estrogenic activity. - Concomitant anticoagulant therapy: monitor for increased bleeding risk. - Pre‑existing liver disease: assess liver function before initiating. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Mensifem can interact with other medicines; awareness of the interaction level is important. Major Interactions (Avoid): - Hormone replacement therapy: may amplify estrogenic effects. - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Strong CYP450 inhibitors: potential elevation of extract constituents. Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): possible serotonergic interaction. - Other estrogenic herbal supplements: additive hormonal activity. - Diuretics: monitor electrolyte balance.